Ignite Creation Date:
2024-05-05 @ 4:51 PM
Last Modification Date:
2024-10-26 @ 9:25 AM
Study NCT ID:
NCT00326885
Status:
COMPLETED
Last Update Posted:
2018-10-17
First Post:
2006-05-15
Brief Title:
Study of the Trifunctional Antibody Catumaxomab to Treat Recurrent Symptomatic Malignant Ascites
Sponsor:
Neovii Biotech
Organization:
Neovii Biotech
Organization Data
Organization:
Neovii Biotech
Class:
INDUSTRY
Study ID:
IP-REM-AC-02-US
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Neovii Biotech
Lead Sponsor Class:
INDUSTRY
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| Fresenius Biotech North America | INDUSTRY |